Independence Blue CrossCommercial · Administrative · Medical Policy · Cardiology, Cardiothoracic Surgery, Critical Care +1 moreLow impact
11.02.26c, Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
Effective date
Not stated in the notice
Identified
Jun 19, 2026
Summary
This is a reissue with no substantive changes to policy 11.02.26c regarding percutaneous left atrial appendage (LAA) closure devices for stroke prevention in atrial fibrillation. The policy continues to cover FDA-approved devices (Watchman and Amplatzer Amulet) as medically necessary when specific stroke and bleeding risk criteria are met. No changes to billing codes, coverage criteria, or documentation requirements have been made in this reissue.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.
02This is a routine annual reissue with no changes to coverage criteria, billing codes, or documentation requirements.
03Billing teams should verify their systems continue to correctly process CPT 33340 claims for qualifying LAA closure procedures with appropriate prior authorization documentation (CHADS2/CHA2DS2-VASc stroke risk score and HAS-BLED bleeding risk score ≥3).
04Maintain current workflows and documentation requirements.
05File this reissue for compliance records and reference.
Codes mentioned
33340I48.0I48.11I48.19I48.20I48.21I48.91
Original notice
11.02.26c, Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
medpolicy.ibx.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.